A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy of Omalizumab in Prevention of Bronchoconstriction Following Environmental Aeroallergen Exposure

被引:1
|
作者
Corren, J. [1 ]
Wood, R. A. [2 ]
Patel, D. [3 ]
Zhu, J. [4 ]
Fish, J. E. [5 ]
机构
[1] Allergy Res Fdn, Allergy Med Clin, Los Angeles, CA USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Cetero Res, Mississauga, ON, Canada
[4] Genentech Inc, San Francisco, CA 94080 USA
[5] Thomas Jefferson Univ, Gladwyne, PA USA
关键词
D O I
10.1016/j.jaci.2009.12.282
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:AB72 / AB72
页数:1
相关论文
共 50 条
  • [1] Efficacy of resveratrol in the treatment of unipolar depression: double-blind randomized placebo-controlled parallel-group study
    Aftanas, L. I.
    Markov, A. A.
    Rikita, M. V.
    Danilenko, K. V.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S189 - S189
  • [2] Efficacy of Zhengtian Pill for migraine prophylaxis: A randomized, multicenter, double-blind, placebo-controlled, parallel-group study
    Cao, Kegang
    Yu, Lihua
    Gao, Ying
    Fan, Yongping
    Zhao, Jianjun
    Zhang, Xuezhi
    Xie, Wei
    Yang, Wenming
    Dong, Mengjiu
    Li, Tao
    Qiao, Xiangyang
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2014, 6 (03) : 259 - 267
  • [3] Lamotrigine for painful polyneuropathy: Randomized, placebo-controlled, double-blind, parallel-group pilot study
    Hart, DE
    Riback, PS
    Calder, CS
    Storey, JR
    Wymer, JP
    Potter, DL
    ANNALS OF NEUROLOGY, 2001, 50 (03) : S35 - S35
  • [4] Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 study
    Keary, Christopher
    Bird, Lynne M.
    de Wit, Marie-Claire
    Hatti, Shivkumar
    Heimer, Gali
    Heussler, Helen
    Kolevzon, Alexander
    Mathews, Adera
    Ochoa-Lubinoff, Cesar
    Tan, Wen-Hann
    Yan, Ying
    Adams, Maxwell
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2023, 47 : 6 - 12
  • [5] Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: A randomized, prospective, parallel-group, double-blind, placebo-controlled study
    Loder, E
    Silberstein, SD
    Abu-Shakra, S
    Mueller, L
    Smith, T
    HEADACHE, 2004, 44 (02): : 120 - 130
  • [6] Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial
    Pasquale Caponnetto
    Davide Campagna
    Jasjit S. Ahluwalia
    Christopher Russell
    Marilena Maglia
    Paolo Marco Riela
    Carmelo Fabio Longo
    Barbara Busa
    Riccardo Polosa
    BMC Medicine, 21
  • [7] Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial
    Caponnetto, Pasquale
    Campagna, Davide
    Ahluwalia, Jasjit S.
    Russell, Christopher
    Maglia, Marilena
    Riela, Paolo Marco
    Longo, Carmelo Fabio
    Busa, Barbara
    Polosa, Riccardo
    BMC MEDICINE, 2023, 21 (01)
  • [8] A randomized double-blind, placebo-controlled study of omalizumab for idiopathic anaphylaxis
    Carter, Melody C.
    Maric, Irina
    Brittain, Erica H.
    Bai, Yun
    Lumbard, Keith
    Bolan, Hyejeong
    Cantave, Daly
    Scott, Linda M.
    Metcalfe, Dean D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (03) : 1004 - +
  • [9] Treatment of partial seizures with gabapentin: Double-blind, placebo-controlled, parallel-group study
    Yamauchi, Toshio
    Kaneko, Sunao
    Yagi, Kazuichi
    Sase, Shinichi
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2006, 60 (04) : 507 - 515
  • [10] The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial
    Sha, Zhongwei
    Hou, Yiping
    Xue, Chunchun
    Li, Ou
    Li, Zhimin
    Wang, Huiru
    Zhang, Wenjing
    Xu, Jian
    TRIALS, 2020, 21 (01)